thiotepa has been researched along with Carcinoma, Lobular in 4 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Carcinoma, Lobular: A type of BREAST CANCER where the abnormal malignant cells form in the lobules, or milk-producing glands, of the breast.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment of breast cancer meningeal carcinomatosis (MC) relies on intrathecal chemotherapy." | 5.39 | Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa. ( Bidard, FC; Comte, A; Cottu, PH; Dieras, V; Dorval, T; Guilhaume, MN; Jdid, W; Kriegel, I; Mignot, L; Pierga, JY; Piperno-Neumann, S, 2013) |
| "Our previous work showed thiotepa could eradicate breast cancer stem cells." | 5.17 | Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of su ( Che, L; Di, L; Jia, J; Jiang, H; Liang, X; Lyerly, HK; Ren, J; Song, G; Wan, F; Wang, X; Yan, Y; Yu, J; Zhang, J; Zhou, X; Zhu, Y, 2013) |
| "Treatment of breast cancer meningeal carcinomatosis (MC) relies on intrathecal chemotherapy." | 1.39 | Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa. ( Bidard, FC; Comte, A; Cottu, PH; Dieras, V; Dorval, T; Guilhaume, MN; Jdid, W; Kriegel, I; Mignot, L; Pierga, JY; Piperno-Neumann, S, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Boo, L | 1 |
| Cimino-Mathews, A | 1 |
| Lubeck, Y | 1 |
| Daletzakis, A | 1 |
| Opdam, M | 1 |
| Sanders, J | 1 |
| Hooijberg, E | 1 |
| van Rossum, A | 1 |
| Loncova, Z | 1 |
| Rieder, D | 1 |
| Trajanoski, Z | 1 |
| Vollebergh, M | 1 |
| Sobral-Leite, M | 1 |
| van de Vijver, K | 1 |
| Broeks, A | 1 |
| van der Wiel, R | 1 |
| van Tinteren, H | 1 |
| Linn, S | 1 |
| Horlings, HM | 1 |
| Kok, M | 1 |
| Comte, A | 1 |
| Jdid, W | 1 |
| Guilhaume, MN | 1 |
| Kriegel, I | 1 |
| Piperno-Neumann, S | 1 |
| Dieras, V | 1 |
| Dorval, T | 1 |
| Pierga, JY | 1 |
| Cottu, PH | 1 |
| Mignot, L | 1 |
| Bidard, FC | 1 |
| Ren, J | 1 |
| Di, L | 1 |
| Song, G | 1 |
| Yu, J | 1 |
| Jia, J | 1 |
| Zhu, Y | 1 |
| Yan, Y | 1 |
| Jiang, H | 1 |
| Liang, X | 1 |
| Che, L | 1 |
| Zhang, J | 1 |
| Wan, F | 1 |
| Wang, X | 1 |
| Zhou, X | 1 |
| Lyerly, HK | 1 |
| Stemmer, SM | 1 |
| Hardan, I | 1 |
| Brenner, HJ | 1 |
| Rizel, S | 1 |
2 trials available for thiotepa and Carcinoma, Lobular
| Article | Year |
|---|---|
Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; BRCA1 Protein; BRCA2 Prote | 2020 |
Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of su
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinom | 2013 |
2 other studies available for thiotepa and Carcinoma, Lobular
| Article | Year |
|---|---|
Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcino | 2013 |
High-dose chemotherapy and autologous stem cell transplant in women with de novo chemosensitive metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Duc | 2004 |